Please use this identifier to cite or link to this item:
Title: Assessment of therapeutic benefit of antiviral therapy in chronic hepatitis C: is hepatic venous pressure gradient a better end point?
Author: Burroughs, Andrew K.
Groszmann, Roberto J.
Bosch i Genover, Jaume
Grace, N. D.
Garcia-Tsao, G.
Patch, D.
García Pagán, Juan Carlos
Dagher, L.
Keywords: Hepatitis C
Virosi (Peixos)
Pressió venosa
Hepatitis C
Virus diseases (Fishes)
Venous pressure
Issue Date: 2002
Publisher: BMJ Group
Abstract: Chronic hepatitis C is a major healthcare problem. The response to antiviral therapy for patients with chronic hepatitis C has previously been defined biochemically and by PCR. However, changes in the hepatic venous pressure gradient (HVPG) may be considered as an adjunctive end point for the therapeutic evaluation of antiviral therapy in chronic hepatitis C. It is a validated technique which is safe, well tolerated, well established, and reproducible. Serial HVPG measurements may be the best way to evaluate response to therapy in chronic hepatitis C.
Note: Reproducció digital del document publicat a:
It is part of: Gut, 2002, vol. 50, núm. 3, p. 425-427
Related resource:
ISSN: 0017-5749
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
546262.pdf83.64 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.